GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » EV-to-EBIT

Prenetics Global (Prenetics Global) EV-to-EBIT

: 3.26 (As of Today)
View and export this data going back to 2022. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Prenetics Global's Enterprise Value is $-24.7 Mil. Prenetics Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-7.6 Mil. Therefore, Prenetics Global's EV-to-EBIT for today is 3.26.

The historical rank and industry rank for Prenetics Global's EV-to-EBIT or its related term are showing as below:

PRE' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.11   Med: 0.15   Max: 7.81
Current: 3.26

During the past 4 years, the highest EV-to-EBIT of Prenetics Global was 7.81. The lowest was -3.11. And the median was 0.15.

PRE's EV-to-EBIT is ranked better than
87.16% of 109 companies
in the Medical Diagnostics & Research industry
Industry Median: 18.95 vs PRE: 3.26

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Prenetics Global's Enterprise Value for the quarter that ended in Sep. 2023 was $28.2 Mil. Prenetics Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-7.6 Mil. Prenetics Global's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -26.85%.


Prenetics Global EV-to-EBIT Historical Data

The historical data trend for Prenetics Global's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
- - - -0.67

Prenetics Global Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.20 -0.67 0.17 1.42 -3.72

Competitive Comparison

For the Diagnostics & Research subindustry, Prenetics Global's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prenetics Global EV-to-EBIT Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Prenetics Global's EV-to-EBIT falls into.



Prenetics Global EV-to-EBIT Calculation

Prenetics Global's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-24.653/-7.569
=3.26

Prenetics Global's current Enterprise Value is $-24.7 Mil.
Prenetics Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prenetics Global  (NAS:PRE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Prenetics Global's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-7.569/28.1936775
=-26.85 %

Prenetics Global's Enterprise Value for the quarter that ended in Sep. 2023 was $28.2 Mil.
Prenetics Global's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prenetics Global EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Prenetics Global's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Prenetics Global (Prenetics Global) Business Description

Traded in Other Exchanges
N/A
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.